A Comprehensive Review of Local Treatment Options for Hidradenitis Suppurativa: Current Strategies and Challenges - Scorecard - MDSpire

A Comprehensive Review of Local Treatment Options for Hidradenitis Suppurativa: Current Strategies and Challenges

  • By

  • Elisa Molinelli

  • Davide Febi

  • Edoardo De Simoni

  • Maria Luisa Dragonetti

  • Irene Richiardi

  • Matteo Candelora

  • Daisy Gambini

  • Sara Belleggia

  • Guendalina Lucarini

  • Oriana Simonetti

  • March 18, 2026

  • 0 min

Share

Clinical Scorecard: A Comprehensive Review of Local Treatment Options for Hidradenitis Suppurativa: Current Strategies and Challenges

At a Glance

CategoryDetail
Condition
Key Mechanisms
Target PopulationPatients with mild to moderate Hidradenitis Suppurativa, considering severity variations.
Care Setting

Key Highlights

  • highlight_4

Guideline-Based Recommendations

Diagnosis

    Management

      Monitoring & Follow-up

      • R
      • e
      • g
      • u
      • l
      • a
      • r
      • a
      • s
      • s
      • e
      • s
      • s
      • m
      • e
      • n
      • t
      • o
      • f
      • s
      • y
      • m
      • p
      • t
      • o
      • m
      • r
      • e
      • l
      • i
      • e
      • f
      • t
      • h
      • r
      • o
      • u
      • g
      • h
      • P
      • R
      • O
      • M
      • s
      • a
      • n
      • d
      • c
      • l
      • i
      • n
      • i
      • c
      • i
      • a
      • n
      • -
      • r
      • e
      • p
      • o
      • r
      • t
      • e
      • d
      • o
      • u
      • t
      • c
      • o
      • m
      • e
      • s
      • ,
      • i
      • n
      • c
      • l
      • u
      • d
      • i
      • n
      • g
      • f
      • r
      • e
      • q
      • u
      • e
      • n
      • c
      • y
      • o
      • f
      • f
      • o
      • l
      • l
      • o
      • w
      • -
      • u
      • p
      • s
      • .

      Risks

        Patient & Prescribing Data

        Topical therapies remain essential; consider emerging options like topical JAK-I, which require further validation.

        Clinical Best Practices

        • best_practice_3

        References

        Original Source(s)

        Related Content